You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
Applicability of EU(7)-PIM criteria in cross-national studies in European countries
|
|---|---|
| Published in |
Therapeutic Advances in Drug Safety, June 2019
|
| DOI | 10.1177/2042098619854014 |
| Pubmed ID | |
| Authors |
Daniela Fialová, Jovana Brkić, Blanca Laffon, Jindra Reissigová, Silvia Grešáková, Soner Dogan, Peter Doro, Ljiljana Tasić, Valentina Marinković, Vanessa Valdiglesias, Solange Costa, Jan Kostřiba |
X Demographics
The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Mexico | 1 | 33% |
| Ireland | 1 | 33% |
| Unknown | 1 | 33% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 3 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 32 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 32 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 7 | 22% |
| Other | 3 | 9% |
| Student > Bachelor | 3 | 9% |
| Lecturer | 2 | 6% |
| Student > Ph. D. Student | 2 | 6% |
| Other | 3 | 9% |
| Unknown | 12 | 38% |
| Readers by discipline | Count | As % |
|---|---|---|
| Pharmacology, Toxicology and Pharmaceutical Science | 12 | 38% |
| Medicine and Dentistry | 3 | 9% |
| Arts and Humanities | 1 | 3% |
| Business, Management and Accounting | 1 | 3% |
| Environmental Science | 1 | 3% |
| Other | 2 | 6% |
| Unknown | 12 | 38% |
Attention Score in Context
This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 28 June 2019.
All research outputs
#14,452,521
of 23,151,189 outputs
Outputs from Therapeutic Advances in Drug Safety
#205
of 302 outputs
Outputs of similar age
#192,135
of 351,422 outputs
Outputs of similar age from Therapeutic Advances in Drug Safety
#14
of 20 outputs
Altmetric has tracked 23,151,189 research outputs across all sources so far. This one is in the 35th percentile – i.e., 35% of other outputs scored the same or lower than it.
So far Altmetric has tracked 302 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 15.1. This one is in the 29th percentile – i.e., 29% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 351,422 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 42nd percentile – i.e., 42% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 20 others from the same source and published within six weeks on either side of this one. This one is in the 25th percentile – i.e., 25% of its contemporaries scored the same or lower than it.